NCT06739057

Brief Summary

This study aims to develop a deep learning-based framework for right ventricular (RV) segmentation, prediction of RV fractional area change (FAC), and identification of pediatric RV dysfunction. The AI model was designed to distinguish between normal pediatric hearts, pulmonary hypertension (PH), and Tetralogy of Fallot (TOF). To improve diagnostic accuracy, the investigators extended the analysis beyond the A4C view by integrating data from both A4C and PSAX views. Additionally, the framework was applied to predict left ventricular ejection fraction (LV EF), further showcasing its versatility and clinical utility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,993

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
10.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
Last Updated

December 20, 2024

Status Verified

December 1, 2024

Enrollment Period

10.7 years

First QC Date

December 12, 2024

Last Update Submit

December 18, 2024

Conditions

Keywords

EchocardiogramRight Ventricle (RV)Pulmonary HypertensionTOF

Outcome Measures

Primary Outcomes (3)

  • RV dysfunction prediction

    FAC \< 35% is considered RV abnormal. The automated extracted FAC values were then used to predict the probability of abnormal RV function.FAC estimation accuracy was evaluated using mean absolute error (MAE), root mean squared error (RMSE), and Pearson correlation coefficient (R). Diagnostic performance metrics included AUC, sensitivity, and specificity for RV function assessment

    10 minutes

  • Congenital Heart Disease Detection

    For CHD detection, classification models were developed to distinguish between normal, PH, and TOF cases by analyzing RV echocardiogram videos. Accuracy, sensitivity, and specificity were used to evaluate the classifications of PH versus normal and PH versus TOF

    10 minutes

  • Left Ventricle Dysfunction

    The performance is assessed by calculating the area under the receiver operating characteristic (ROC) curve , evaluating the model's accuracy in detecting abnormal EF values.

    10 minutes

Study Arms (4)

RV FAC Prediction Cohort

This cohort is designed to predict pediatric RV FAC using a deep learning model based on echocardiograms

RV Disease Classification Cohort

The cohort is designed to employ a deep learning model to differentiate between normal pediatric hearts and pulmonary hypertension (PH), as well as between Tetralogy of Fallot (TOF) and PH, using echocardiograms.

RV Function Assessment and Disease Classification Using A4C and PSAX View Cohorts

The cohort is designed to utilize A4C and PSAX echocardiographic views for pediatric RV function assessment and disease classification using deep learning models.

LV Ejection Fraction (EF) Prediction Cohort

The cohort is designed to validate our new deep learning model for LV EF assessment.

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Two groups of children are included. Group I: Children with normal right ventricular anatomy and function assessment based on screening echocardiograms and physcian follow up. Group II: Children with right ventricular abnormalities who have potential risk of adverse outcomes.

You may qualify if:

  • Patients aged 0-18 years old.
  • Patients with the following diagnoses (defined as abnormal RVs): premature infants with lung disease, congenital heart disease with systemic right ventricles, surgically repaired congenital heart disease resulting in pressure and/or volume load on the RV (tetralogy of Fallot, Double outlet right ventricle, etc.), and idiopathic pulmonary hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

Ventricular Dysfunction, LeftHypertension, Pulmonary

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular DiseasesLung DiseasesRespiratory Tract DiseasesHypertensionVascular Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiothoracic Surgery (Pediatric Cardiac Surgery) and of Pediatrics (Cardiology), Stanford University School of Medicine

Study Record Dates

First Submitted

December 12, 2024

First Posted

December 18, 2024

Study Start

January 1, 2014

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

December 20, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations